Genetic Diversity of <i>Staphylococcus aureus</i> Strains from a Tertiary Care Hospital in Rawalpindi, Pakistan

<i>Staphylococcus aureus</i> is an important healthcare-associated bacterium that causes a multitude of infections in humans such as superficial skin and soft tissue infections, necrotizing pneumonia, foodborne illnesses and postsurgical infections. Treatment of <i>S. aureus</i&...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Muhammad Ali Syed, Bushra Jamil, Hazem Ramadan, Maria Rukan, Shahzad Ali, Shahid Ahmad Abbasi, Tiffanie A. Woodley, Charlene R. Jackson
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/067a9c63777e477abd4653a60326b46d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:<i>Staphylococcus aureus</i> is an important healthcare-associated bacterium that causes a multitude of infections in humans such as superficial skin and soft tissue infections, necrotizing pneumonia, foodborne illnesses and postsurgical infections. Treatment of <i>S. aureus</i> infections has become more complicated due to the emergence of Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA), some of which are multidrug resistant. The present study aimed to characterize <i>S. aureus</i> isolates from a tertiary care hospital in the Rawalpindi district of Pakistan. Staphylococci were isolated from 300 clinical samples collected from January 2018 to January 2019 and <i>S. aureus</i> isolates were tested for antimicrobial susceptibility and analyzed using Pulsed-Field Gel Electrophoresis (PFGE), Multi-Locus Sequence Typing (MLST), staphylococcal cassette chromosome <i>mec</i> (SCC<i>mec</i>) and <i>spa</i> typing. Approximately 25.3% (76/300) of the clinical samples were positive for <i>S. aureus</i>; of those, 88.2% (67/76) were <i>mec</i>A+ (MRSA). In addition to the β-lactam antibiotics, high levels of resistance were also found to the fluoroquinolones (ciprofloxacin, gatifloxacin and levofloxacin (73.7% each)). Of the 23 different <i>spa</i> types identified, the majority of isolates belonged to <i>spa</i> type t632 and t657 (9/66; 13.6% each <i>spa</i> type). ST772-t657 (Bengal Bay clone) was the most commonly identified clone in this study although other clones circulating around different regions of the world were also found indicating the diversity in MRSA isolates from this area of Pakistan. This study emphasizes the need to monitor MRSA in the clinical setting for improved infection control and treatment options.